Search Results - "Kupatt, C."

Refine Results
  1. 1
  2. 2
  3. 3

    Will our cardiomyopathy patients accept gene therapy? by Doevendans, P. A., Kupatt, C., Giacca, M., Glijnis, P.

    Published in Netherlands heart journal (01-07-2022)
    “…Novel techniques such as gene therapy are becoming available in an attempt to cure inherited diseases. Before these new therapies can be offered to patients,…”
    Get full text
    Journal Article
  4. 4

    Contrast-induced acute kidney injury after computed tomography prior to transcatheter aortic valve implantation by Jochheim, D, Schneider, V.-S, Schwarz, F, Kupatt, C, Lange, P, Reiser, M, Massberg, S, Gutiérrez-Chico, J.-L, Mehilli, J, Becker, H.-C

    Published in Clinical radiology (01-10-2014)
    “…Aim To identify independent predictors of contrast medium-induced acute kidney injury (CI-AKI) after enhanced multidetector-row computed tomography (MDCT)…”
    Get full text
    Journal Article
  5. 5

    Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia by Jeremias, I, Kupatt, C, Martin-Villalba, A, Habazettl, H, Schenkel, J, Boekstegers, P, Debatin, K M

    Published in Circulation (New York, N.Y.) (22-08-2000)
    “…The death of cardiac cells during ischemia and reperfusion is partially mediated by apoptosis, as seen, eg, in autopsy material of patients after acute…”
    Get full text
    Journal Article
  6. 6

    Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors by Raake, P W, Hinkel, R, Müller, S, Delker, S, Kreuzpointner, R, Kupatt, C, Katus, H A, Kleinschmidt, J A, Boekstegers, P, Müller, O J

    Published in Gene therapy (01-01-2008)
    “…Cornerstone for an efficient cardiac gene therapy is the need for a vector system, which enables selective and long-term expression of the gene of interest. In…”
    Get full text
    Journal Article
  7. 7

    Inhibition of Nuclear Factor κB Activation Attenuates Apoptosis Resistance in Lymphoid Cells by Jeremias, I., Kupatt, C., Baumann, B., Herr, I., Wirth, T., Debatin, K.M.

    Published in Blood (15-06-1998)
    “…Death-inducing ligands (DILs) such as tumor necrosis factor α (TNFα) or the cytotoxic drug doxorubicin have been shown to activate a nuclear factor κB…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins by Boekstegers, P, von Degenfeld, G, Giehrl, W, Heinrich, D, Hullin, R, Kupatt, C, Steinbeck, G, Baretton, G, Middeler, G, Katus, H, Franz, W M

    Published in Gene therapy (01-02-2000)
    “…Catheter-based percutaneous transluminal gene delivery (PTGD) into the coronary artery still falls behind the expectations of an efficient myocardial gene…”
    Get full text
    Journal Article
  10. 10

    Endothelial function and hemostasis by Becker, B F, Heindl, B, Kupatt, C, Zahler, S

    Published in Clinical research in cardiology (01-03-2000)
    “…The vascular endothelium influences not only the three classically interacting components of hemostasis: the vessel, the blood platelets and the clotting and…”
    Get full text
    Journal Article
  11. 11

    Endothelial retargeting of AAV9 in vivo by Bozoglu, T, Lee, S, Ziegler, T, Kupatt, C

    Published in European heart journal (03-10-2022)
    “…Abstract Background Adeno-associated virus (AAV) is favorable choice for gene transfer and gene editing applications in vivo, due to its low integration rate…”
    Get full text
    Journal Article
  12. 12

    AAV based gene delivery to myocardium in rodents and pigs by Xiaofeng, J., Burdorf, L., Postrach, J., Bauer, A., Thein, E., Hinkel, R., Schumann, N., Büning, H., Reichart, B., Kupatt, C., Schmoeckel, M.

    Published in Xenotransplantation (Københaven) (01-03-2010)
    “…Objective:  To optimize transgene expression levels after AAV‐mediated gene transfer different delivery methods were compared in a rat (A) and porcine (B)…”
    Get full text
    Journal Article
  13. 13

    AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury by Hinkel, Rabea, Ramanujam, Deepak, Kaczmarek, Veronika, Howe, Andrea, Klett, Katharina, Beck, Christina, Dueck, Anne, Thum, Thomas, Laugwitz, Karl-Ludwig, Maegdefessel, Lars, Weber, Christian, Kupatt, Christian, Engelhardt, Stefan

    “…miR-21 is a central regulator of cardiac fibrosis, and its inhibition in small-animal models has been shown to be an effective antifibrotic strategy in various…”
    Get full text
    Journal Article
  14. 14

    Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to vascular brachytherapy by Pohl, T, Kupatt, C, Steinbeck, G, Boekstegers, P

    Published in Clinical research in cardiology (01-06-2005)
    “…With the use of coronary stents for the treatment of coronary artery disease, in-stent restenosis became a major clinical problem. In this non-randomized…”
    Get full text
    Journal Article
  15. 15

    AAV.Cas9 and AAV.SERCA2a strategies to mitigate heart failure in DMD pigs by Baehr, A, Hornaschewitz, N, Stirm, M, Hoppmann, P, Bozoglu, T, Klymiuk, N, Laugwitz, K L, Moretti, A, Wolf, E, Hajjar, R, Kupatt, C

    Published in European heart journal (09-11-2023)
    “…Abstract Aims Duchenne muscular dystrophy is a devastating disease affecting skeletal muscle and heart, which is caused by loss-of-function mutations in the…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Targeted overexpression of regnase-1 in the aorta prevents aneurysm growth in a murine model of Marfan syndrome by Noormalal, M, Remes, A, Schmiedel, N, Matzen, A, Hille, S, Bozoglu, T, Wolf, A, Zaradzki, M, Karck, M, Kupatt, C, Frank, D, Frey, N, Mueller, O J

    Published in European heart journal (03-10-2022)
    “…Abstract Background/Introduction Marfan syndrome is a rare genetic disorder caused by mutations in the fibrillin-1 gene. This markedly affects the…”
    Get full text
    Journal Article
  19. 19

    Man-machine interaction-based phenotyping preprocedurally identifies patients with severe aortic stenosis, who will not recover from cardiac damage following transcatheter aortic valve replacement by Rippen, E, Lachmann, M, Schuster, T, Xhepa, E, Von Scheidt, M, Harmsen, G, Yuasa, S, Kupatt, C, Joner, M, Laugwitz, K L

    Published in European heart journal (03-10-2022)
    “…Abstract Background Severe aortic stenosis (AS) can lead to left heart dysfunction, pulmonary hypertension (PH), and eventually right heart failure. Clinical…”
    Get full text
    Journal Article
  20. 20

    Effect of renin angiotensin system blockade following transcatheter aortic valve replacement is dose dependent by Ledwoch, J, Olbrich, I, Poch, F, Thalmann, R, Fellner, C, Stundl, A, Bradaric, C, Laugwitz, K.L, Kupatt, C

    Published in European heart journal (01-11-2020)
    “…Abstract Background There is growing body of evidence from retrospective studies that inhibition of the renin angiotensin system (RAS) improves outcome after…”
    Get full text
    Journal Article